사람의 짧은 나선형 펩티드-1 을 유효성분으로 함유하는항균활성 약학적 조성물
    2.
    发明公开
    사람의 짧은 나선형 펩티드-1 을 유효성분으로 함유하는항균활성 약학적 조성물 失效
    含有人类短链蛋白-1作为活性成分的抗微生物活性药物组合物

    公开(公告)号:KR1020080048016A

    公开(公告)日:2008-05-30

    申请号:KR1020080044678

    申请日:2008-05-14

    Abstract: A human short helical peptide-1(hSHP-1) secreted from human is provided to show strong antimicrobial, anticancer and immunoreaction stimulating activities with no allergic reaction, thereby being used as a pharmaceutical composition for preventing and treating infectious mucosal diseases. A pharmaceutical composition for treating infectious diseases of oral cavity, eyeball, hair, skin, nasal cavity, gastrointestinal tract, peritoneum, pleura, vagina, prostate, bladder, urethra, bursa, hypophysis membrane, outer ear, inner ear, bone marrow or an internal important organs comprises at least one peptide of SEQ ID : NOs. 3, 4, 5, 6, and 7 or a tandem repeat thereof as an effective ingredient, wherein pathogen of the infectious disease is Gram negative or Gram positive bacteria, fungus, encapsulated virus or methicillin-resistant bacteria.

    Abstract translation: 提供从人分泌的人类短螺旋肽-1(hSHP-1),以显示强的抗微生物,抗癌和免疫反应刺激活性,无过敏反应,从而用作预防和治疗感染性粘膜疾病的药物组合物。 一种用于治疗口腔,眼球,头发,皮肤,鼻腔,胃肠道,腹膜,胸膜,阴道,前列腺,膀胱,尿道,粘液囊,垂体膜,外耳,内耳,骨髓或骨髓的感染性疾病的药物组合物 内部重要器官包含至少一种SEQ ID NO:的肽。 3,4,5,6和7或其串联重复作为有效成分,其中感染性疾病的病原体是革兰氏阴性或革兰氏阳性菌,真菌,包封的病毒或耐甲氧西林的细菌。

    항균, 항암, 면역자극 활성을 가지는, 사람의 짧은 나선형펩티드-1 및 이의 용도
    4.
    发明公开
    항균, 항암, 면역자극 활성을 가지는, 사람의 짧은 나선형펩티드-1 및 이의 용도 失效
    具有抗微生物,抗肿瘤和免疫刺激活性的人类短链蛋白-1及其用途

    公开(公告)号:KR1020070116442A

    公开(公告)日:2007-12-10

    申请号:KR1020060050487

    申请日:2006-06-05

    CPC classification number: C07K14/4723 A61K38/00

    Abstract: A novel human short helical peptide-1(hSHP-1) is provided which is specifically expressed in human and has antimicrobial, antitumor, and immune stimulating activity. And a pharmaceutical composition for antimicrobial, antitumor, and immune stimulating activity and antimicrobial living articles comprising the same peptide are provided. A peptide having anti-microbial, anti-tumor or immune stimulating activity is selected from the group consisting of: (a) an N-terminal of the peptide selected from the group consisting of 12th to 31st amino acid residues of a sequence described in SEQ ID : NO. 2, and a C-terminal of the peptide selected from the group consisting of 45th to 46th amino acid residues of a sequence described in SEQ ID : NO. 2 and having more than 16-mer; and (b) a tandem repeat of the peptide(a). A pharmaceutical composition for treating infectious diseases of oral cavity, eyeball, hair, skin, nasal cavity, gastrointestine, peritoneum, pleura, prostate, bladder, urinary tract, articular capsule, pituitary gland diaphragm, outer ear, inner ear, bone marrow or internal important organs comprises the peptide as an effective ingredient.

    Abstract translation: 提供了一种新型人类短螺旋肽-1(hSHP-1),其在人体中特异性表达并具有抗微生物,抗肿瘤和免疫刺激活性。 并且提供了包含相同肽的抗微生物,抗肿瘤和免疫刺激活性的药物组合物和抗微生物生物制品。 具有抗微生物,抗肿瘤或免疫刺激活性的肽选自:(a)肽的N-末端,其选自SEQ ID NO:12所示序列的第12位至第31位氨基酸残基 证件号码。 2和选自SEQ ID NO:1所示序列的第45位至第46位氨基酸残基的肽的C-末端。 2并且具有超过16个词; 和(b)肽(a)的串联重复。 一种用于治疗口腔,眼球,头发,皮肤,鼻腔,胃肠道,腹膜,胸膜,前列腺,膀胱,尿道,关节囊,垂体腺膜,外耳,内耳,骨髓或内部的感染性疾病的药物组合物 重要器官包括肽作为有效成分。

Patent Agency Ranking